OSL completes $7 M Placement and announces $1 M SPP
Filed with ASX · · 6 pages · English
In the deck
Earlier from OncoSil Medical
- G-BA Approval received for OncoSil Device
- Appendix 4E Preliminary Financial Report
- Successful Treatment with OncoSil Device in Turkiye
- Australian institution to invest $2.7 million in OSL
- $5.3 million raised under Entitlement Offer
Later from OncoSil Medical
- Prospectus 2024 Share Purchase Plan (SPP) Offer
- Oncosil completes $1 million Share Purchase Plan (SPP)
- OncoSil receives $1.05m R&D tax incentive
- OncoSil Medical Receives MDR Approval
- 120 German Hospitals entitled to negotiate fee for OncoSil
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical